CN1196677A - 很低剂量药物固体剂型的制备方法 - Google Patents

很低剂量药物固体剂型的制备方法 Download PDF

Info

Publication number
CN1196677A
CN1196677A CN96197054A CN96197054A CN1196677A CN 1196677 A CN1196677 A CN 1196677A CN 96197054 A CN96197054 A CN 96197054A CN 96197054 A CN96197054 A CN 96197054A CN 1196677 A CN1196677 A CN 1196677A
Authority
CN
China
Prior art keywords
composition
carrier
drug
dose
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96197054A
Other languages
English (en)
Chinese (zh)
Inventor
J·A·纳佩尔
N·莫蒂梅尔
K·T·奥布里恩
S·J·马内克
R·库马尔
M·S·G·克拉克
J·M·罗顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1196677A publication Critical patent/CN1196677A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN96197054A 1995-07-29 1996-07-29 很低剂量药物固体剂型的制备方法 Pending CN1196677A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9515624.6 1995-07-29
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GB9606684.0 1996-03-29
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
CN1196677A true CN1196677A (zh) 1998-10-21

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96197054A Pending CN1196677A (zh) 1995-07-29 1996-07-29 很低剂量药物固体剂型的制备方法

Country Status (25)

Country Link
EP (1) EP0841902A2 (de)
JP (1) JPH11510493A (de)
KR (1) KR19990035972A (de)
CN (1) CN1196677A (de)
AP (1) AP858A (de)
AR (1) AR004178A1 (de)
AU (1) AU716961B2 (de)
BG (1) BG102266A (de)
BR (1) BR9609804A (de)
CA (1) CA2228048A1 (de)
CZ (1) CZ24798A3 (de)
DZ (1) DZ2077A1 (de)
EA (2) EA199901055A1 (de)
HU (1) HUP9900521A3 (de)
IL (1) IL122897A0 (de)
MA (1) MA23953A1 (de)
MX (1) MX9800809A (de)
NO (1) NO980384L (de)
NZ (1) NZ315632A (de)
OA (1) OA10659A (de)
PL (1) PL325242A1 (de)
SK (1) SK11098A3 (de)
TR (1) TR199800156T1 (de)
UY (1) UY24297A1 (de)
WO (1) WO1997004750A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
IL138192A0 (en) 1998-03-11 2001-11-25 Smithkline Beecham Plc Controlled release oral dosage forms
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US7867990B2 (en) 2000-12-14 2011-01-11 Ortho-Mcneil Pharmaceutical, Inc. Steroid hormone products and methods for preparing them
WO2005097076A2 (en) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Low dose pharmaceutical products
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
IL122897A0 (en) 1998-08-16
EA000740B1 (ru) 2000-02-28
JPH11510493A (ja) 1999-09-14
WO1997004750A3 (en) 1997-03-27
BG102266A (en) 1998-10-30
SK11098A3 (en) 1998-07-08
AR004178A1 (es) 1998-11-04
PL325242A1 (en) 1998-07-06
DZ2077A1 (fr) 2002-07-22
BR9609804A (pt) 1999-07-06
MA23953A1 (fr) 1997-04-01
WO1997004750A2 (en) 1997-02-13
HUP9900521A3 (en) 2001-04-28
MX9800809A (es) 1998-04-30
AP9801170A0 (en) 1998-01-31
NZ315632A (en) 1999-11-29
UY24297A1 (es) 1997-01-23
AU6738496A (en) 1997-02-26
KR19990035972A (ko) 1999-05-25
CZ24798A3 (cs) 1998-06-17
AU716961B2 (en) 2000-03-09
HUP9900521A2 (hu) 1999-06-28
OA10659A (en) 2002-09-18
TR199800156T1 (xx) 1998-04-21
EA199901055A1 (ru) 2000-06-26
EP0841902A2 (de) 1998-05-20
NO980384L (no) 1998-03-26
NO980384D0 (no) 1998-01-28
AP858A (en) 2000-07-12
CA2228048A1 (en) 1997-02-13
EA199800179A1 (ru) 1998-10-29

Similar Documents

Publication Publication Date Title
US6214386B1 (en) Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
SK11652002A3 (sk) Prostriedok s nízkou dávkou entekavírusu a jeho použitie
JP2001511156A (ja) 高いバイオアベイラビリティーを有するフェノフィブレート医薬組成物及びそれを調製するための方法
KR20130122019A (ko) 약학 조성물
AU2007252994A1 (en) Pharmaceutical compositions comprising implitapide and methods of using same
HK1213814A1 (zh) 双氯芬酸制剂和使用方法
IE853176L (en) Stable £n-(2-hydroxyethyl)-nicotinamide nitrate (ester)|¹compositions
US5464612A (en) Solid preparation comprising ion exchanger and active agent
JP4127740B2 (ja) 安定化したベンズイミダゾール系化合物含有組成物
EP0862421B1 (de) Pharmazeutische zubereitung mit schneller freisetzung
US20020150618A1 (en) Process for preparing solid dosage forms of very low-dose drugs
CN1196677A (zh) 很低剂量药物固体剂型的制备方法
MXPA98000809A (en) Procedure to prepare forms of solid doses of very low dose of farm
SK50132006A3 (sk) Flukonazolové kapsuly so zlepšeným uvoľňovaním
AU751607B2 (en) Method of treatment of dementia
CZ295584B6 (cs) Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
JP2003095980A (ja) 潮解性物質を含有する組成物
JP2002138034A (ja) 苦味マスキングチュアブル錠およびその製造方法
CN109833308B (zh) 一种罗沙替丁醋酸酯药用盐的载药微丸及其制备方法和应用
HK40051811A (en) Diclofenac formulations and methods of use
EP1438961B1 (de) Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer
CA2603316C (en) Combined-step process for pharmaceutical compositions
KR0185293B1 (ko) 터부탈린설페이트-구아이페네신 서방성 복합제제 (1)
HK40050171A (en) Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate
HK1070289A (en) Fenofibrate pharmaceutical composition with a higher bioavailability and its manufacturing process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication